HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

SOLV

Solventum Corporation (NYSE)

Healthcare — Medical Instruments & Supplies

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Buy 2.5 / 5 13 analysts
$79.78
+$1.43 (+1.83%)
Target: $82.15 (3.0%)
Sign in to add SOLV to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$13.82B
P/E Ratio (TTM)9.76
Forward P/E11.32
EPS (TTM)$8.17
Dividend Yield-
Profit Margin17.33%
Revenue Growth-3.00%
ROE34.79%
Debt/Equity106.46
Recommendation Buy 2.5
Analyst Target$82.15
Analysts13
Indexes NYSE

Technical Indicators

RSI (14)51.5
Beta0.75
SMA 20-
SMA 40-
52-Week High$88.20
52-Week Low$62.38
50-Day Avg$74.68
200-Day Avg$74.54
Avg Volume$1.72M
Volume9.5K

Performance Analysis

BULLISH

SOLV shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 67% of its 52-week range.
~ RSI at 51.5 is in neutral territory.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
+ P/E of 9.8 suggests the stock may be undervalued.
- Revenue declined 3.0% year-over-year.
+ Wall Street consensus is "Buy" from 13 analysts.
+ Average analyst target of $82.15 implies 3.0% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:32 UTC

Back to Screener Export Report